je.st
news
Tag: announces approval
Novartis announces FDA approval of Entresto to reduce risk of...
2015-07-09 05:43:33| Biotech - Topix.net
Novartis announced today that the US Food and Drug Administration has approved Entresto tablets, previously known as LCZ696, to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction . It is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other angiotensin receptor blocker .
Alon Blue Square Announces Board Approval to Proceed With Rights Offering to Existing Shareholders
2015-07-06 13:14:45| Grocery - Topix.net
Alon Blue Square Israel Ltd. announced today that the Board of Directors of the Company has resolved to move forward with a rights offering to its existing holders of ordinary shares and American Depositary Shares to acquire the Company's ordinary shares and American Depositary Shares, respectively. The Company intends to raise up to in gross proceeds assuming that all the offered rights are fully exercised.
Tags: rights
board
blue
existing
Teva Announces FDA Approval Of ProAir RespiClick
2015-04-22 08:17:13| dairynetwork News Articles
Teva Pharmaceutical Industries Ltd., recently announced that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate) inhalation powder, a breath-actuated, multi-dose, dry-powder, short-acting beta-agonist (SABA) inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease; and for the prevention of exercise-induced bronchospasm (EIB) in patients 12 years of age and older
Tags: approval
announces
fda
teva
Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC
2015-02-14 13:04:00| Biotech - Topix.net
Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer . LENVIMA was approved following a priority review by the FDA, which is designated for drugs the FDA believes have the potential to provide a significant improvement in the treatment of a serious condition.
Tags: treatment
approval
announces
fda
Zoetis Announces Implant Approval For Heifers
2014-09-16 17:12:52| Beef
SYNOVEX CHOICE®, which has helped increase gain in feedlot steers for many years, has been approved for use in feedlot heifers to increase average daily gain and improve feed efficiency in heifers, according to Zoetis. The U.S. Food and Drug Administration (FDA) approval for use in heifers means feedlot managers can use the same implant for all cattle. For more than 12 years, SYNOVEX CHOICE has helped optimize weight gain in feedlot steers through the 10:1 ratio of trenbolone acetate (TBA) to estradiol-17B (E2).1 read more
Tags: approval
announces
implant
heifers